{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:17:42Z","timestamp":1791173862283,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2005,4,6]],"date-time":"2005-04-06T00:00:00Z","timestamp":1112745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1038\/sj.npp.1300720","type":"journal-article","created":{"date-parts":[[2005,4,6]],"date-time":"2005-04-06T11:00:39Z","timestamp":1112785239000},"page":"2035-2045","source":"Crossref","is-referenced-by-count":148,"title":["Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems"],"prefix":"10.1038","volume":"30","author":[{"given":"Marcello","family":"Solinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,4,6]]},"reference":[{"key":"BF1300720_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0091-6773(75)91684-3","volume":"15","author":"EL Abel","year":"1975","unstructured":"Abel EL (1975). Cannabis: effects on hunger and thirst. Behav Biol 15: 255\u2013281.","journal-title":"Behav Biol"},{"key":"BF1300720_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0091-3057(96)00445-5","volume":"57","author":"JM Arnold","year":"1997","unstructured":"Arnold JM, Roberts DC (1997). A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57: 441\u2013447.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300720_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s002130050326","volume":"132","author":"M Arnone","year":"1997","unstructured":"Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P et al (1997). Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 132: 104\u2013106.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR4","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1046\/j.1460-9568.2003.02951.x","volume":"18","author":"F Berrendero","year":"2003","unstructured":"Berrendero F, Mendizabal V, Murtra P, Kieffer BL, Maldonado R (2003). Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice. Eur J Neurosci 18: 2197\u20132202.","journal-title":"Eur J Neurosci"},{"key":"BF1300720_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0163-7258(02)00257-7","volume":"95","author":"EM Berry","year":"2002","unstructured":"Berry EM, Mechoulam R (2002). Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol Ther 95: 185\u2013190.","journal-title":"Pharmacol Ther"},{"key":"BF1300720_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/BF02245916","volume":"102","author":"JP Chen","year":"1990","unstructured":"Chen JP, Paredes W, Li J, Smith D, Lowinson J, Gardner EL (1990). Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berl) 102: 156\u2013162.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR7","doi-asserted-by":"publisher","first-page":"PL113","DOI":"10.1016\/S0024-3205(98)00322-1","volume":"63","author":"G Colombo","year":"1998","unstructured":"Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL (1998). Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63: PL113\u2013117.","journal-title":"Life Sci"},{"key":"BF1300720_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejphar.2004.07.009","volume":"500","author":"SJ Cooper","year":"2004","unstructured":"Cooper SJ (2004). Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite. Eur J Pharmacol 500: 37\u201349.","journal-title":"Eur J Pharmacol"},{"key":"BF1300720_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-4613-9000-8_5","volume-title":"Opioids, Bulimia and Alcohol Abuse and Alcoholism","author":"SJ Cooper","year":"1990","unstructured":"Cooper SJ, Kirkham TC (1990). Basic mechanisms of opioids' effects on eating and drinking. In: Reid LD (ed). Opioids, Bulimia and Alcohol Abuse and Alcoholism. Springer: New York. pp 91\u2013110."},{"key":"BF1300720_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0166-4328(00)00311-9","volume":"118","author":"G Cossu","year":"2001","unstructured":"Cossu G, Ledent C, Fattore L, Imperato A, Bohme GA, Parmentier M et al (2001). Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 118: 61\u201365.","journal-title":"Behav Brain Res"},{"key":"BF1300720_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/sj.ijo.0802250","volume":"27","author":"D Cota","year":"2003","unstructured":"Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R et al (2003). Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 27: 289\u2013301.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF1300720_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2165\/00023210-200317030-00004","volume":"17","author":"JL Croxford","year":"2003","unstructured":"Croxford JL (2003). Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 17: 179\u2013202.","journal-title":"CNS Drugs"},{"key":"BF1300720_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/nm1001-1151","volume":"7","author":"TJ De Vries","year":"2001","unstructured":"De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J et al (2001). A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7: 1151\u20131154.","journal-title":"Nat Med"},{"key":"BF1300720_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"V Di Marzo","year":"2001","unstructured":"Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z et al (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822\u2013825.","journal-title":"Nature"},{"key":"BF1300720_CR15","first-page":"430","volume":"5","author":"JR Fernandez","year":"2004","unstructured":"Fernandez JR, Allison DB (2004). Rimonabant Sanofi\u2013Synthelabo. Curr Opin Invest Drugs 5: 430\u2013435.","journal-title":"Curr Opin Invest Drugs"},{"key":"BF1300720_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0091-3057(00)00359-2","volume":"67","author":"CS Freedland","year":"2000","unstructured":"Freedland CS, Poston JS, Porrino LJ (2000). Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav 67: 265\u2013270.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300720_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0014-2999(99)00170-3","volume":"370","author":"JE Gallate","year":"1999","unstructured":"Gallate JE, Saharov T, Mallet PE, McGregor IS (1999). Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370: 233\u2013240.","journal-title":"Eur J Pharmacol"},{"key":"BF1300720_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000054468","volume":"70","author":"S Gonzalez","year":"1999","unstructured":"Gonzalez S, Manzanares J, Berrendero F, Wenger T, Corchero J, Bisogno T et al (1999). Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland. Neuroendocrinology 70: 137\u2013145.","journal-title":"Neuroendocrinology"},{"key":"BF1300720_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/1355621031000117383","volume":"8","author":"S Gonzalez","year":"2003","unstructured":"Gonzalez S, Schmid PC, Fernandez-Ruiz J, Krebsbach R, Schmid HH, Ramos JA (2003). Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats. Addict Biol 8: 159\u2013166.","journal-title":"Addict Biol"},{"key":"BF1300720_CR20","first-page":"147","volume-title":"Drug Receptor Subtypes and Ingestive Behaviour","author":"B Gosnell","year":"1996","unstructured":"Gosnell B, Levine AS (1996). Stimulation of ingestive behaviour by preferential and selective opioid agonists. In: Cooper SJ and Clifton PG (eds). Drug Receptor Subtypes and Ingestive Behaviour. Academic Press: San Diego. pp 147\u2013166."},{"key":"BF1300720_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF00437619","volume":"43","author":"RR Griffiths","year":"1975","unstructured":"Griffiths RR, Findley JD, Brady JV, Dolan-Gutcher K, Robinson WW (1975). Comparison of progressive-ratio performance maintained by cocaine, methylphenidate and secobarbital. Psychopharmacologia 43: 81\u201383.","journal-title":"Psychopharmacologia"},{"key":"BF1300720_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0014-2999(00)00059-5","volume":"392","author":"S Hao","year":"2000","unstructured":"Hao S, Avraham Y, Mechoulam R, Berry EM (2000). Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 392: 147\u2013156.","journal-title":"Eur J Pharmacol"},{"key":"BF1300720_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1079\/BJN2003942","volume":"90","author":"JA Harrold","year":"2003","unstructured":"Harrold JA, Williams G (2003). The cannabinoid system: a role in both the homeostatic and hedonic control of eating? Br J Nutr 90: 729\u2013734.","journal-title":"Br J Nutr"},{"key":"BF1300720_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","volume":"11","author":"M Herkenham","year":"1991","unstructured":"Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11: 563\u2013583.","journal-title":"J Neurosci"},{"key":"BF1300720_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00213-002-1263-3","volume":"165","author":"S Higgs","year":"2003","unstructured":"Higgs S, Williams CM, Kirkham TC (2003). Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) 165: 370\u2013377.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1126\/science.134.3483.943","volume":"134","author":"W Hodos","year":"1961","unstructured":"Hodos W (1961). Progressive ratio as a measure of reward strength. Science 134: 943\u2013944.","journal-title":"Science"},{"key":"BF1300720_CR27","first-page":"380","volume":"187","author":"SG Holtzman","year":"1973","unstructured":"Holtzman SG, Jewett RE (1973). Stimulation of behavior in the rat by cyclazocine: effects of naloxone. J Pharmacol Exp Ther 187: 380\u2013390.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300720_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0090-6980(02)00060-6","volume":"68\u201369","author":"AC Howlett","year":"2002","unstructured":"Howlett AC (2002). The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68\u201369: 619\u2013631.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"BF1300720_CR29","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/sj.bjp.0704379","volume":"134","author":"N Jamshidi","year":"2001","unstructured":"Jamshidi N, Taylor DA (2001). Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134: 1151\u20131154.","journal-title":"Br J Pharmacol"},{"key":"BF1300720_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0091-3057(02)00938-3","volume":"73","author":"TU Jarbe","year":"2002","unstructured":"Jarbe TU, Andrzejewski ME, DiPatrizio NV (2002). Interactions between the CB1 receptor agonist delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited. Pharmacol Biochem Behav 73: 911\u2013919.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300720_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s00213-003-1693-6","volume":"173","author":"Z Justinova","year":"2004","unstructured":"Justinova Z, Tanda G, Munzar P, Goldberg SR (2004). The opioid antagonist naltrexone reduces the reinforcing effects of delta 9 tetrahydrocannabinol (THC) in squirrel monkeys. Psychopharmacology (Berl) 173: 186\u2013194.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00213-004-1990-8","volume":"177","author":"M Kalinichev","year":"2004","unstructured":"Kalinichev M, White DA, Holtzman SG (2004). Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitization. Psychopharmacology (Berl) 177: 61\u201367.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0031-9384(02)00751-5","volume":"76","author":"AE Kelley","year":"2002","unstructured":"Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, Zhang M (2002). Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 76: 365\u2013377.","journal-title":"Physiol Behav"},{"key":"BF1300720_CR34","doi-asserted-by":"publisher","first-page":"R343","DOI":"10.1152\/ajpregu.00706.2002","volume":"284","author":"TC Kirkham","year":"2003","unstructured":"Kirkham TC (2003). Endogenous cannabinoids: a new target in the treatment of obesity. Am J Physiol Regul Integr Comp Physiol 284: R343\u2013344.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BF1300720_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s002130000596","volume":"153","author":"TC Kirkham","year":"2001","unstructured":"Kirkham TC, Williams CM (2001). Synergistic efects of opioid and cannabinoid antagonists on food intake. Psychopharmacology (Berl) 153: 267\u2013270.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1126\/science.283.5400.401","volume":"283","author":"C Ledent","year":"1999","unstructured":"Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F et al (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401\u2013404.","journal-title":"Science"},{"key":"BF1300720_CR37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1749-6632.2003.tb03180.x","volume":"994","author":"MJ Low","year":"2003","unstructured":"Low MJ, Hayward MD, Appleyard SM, Rubinstein M (2003). State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin. Ann NY Acad Sci 994: 192\u2013201.","journal-title":"Ann NY Acad Sci"},{"key":"BF1300720_CR38","first-page":"2445","volume":"7","author":"A Mansour","year":"1987","unstructured":"Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1987). Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7: 2445\u20132464.","journal-title":"J Neurosci"},{"key":"BF1300720_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","volume":"20","author":"J Manzanares","year":"1999","unstructured":"Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA (1999). Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20: 287\u2013294.","journal-title":"Trends Pharmacol Sci"},{"key":"BF1300720_CR40","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1046\/j.1460-9568.2000.00287.x","volume":"12","author":"M Martin","year":"2000","unstructured":"Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2000). Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci 12: 4038\u20134046.","journal-title":"Eur J Neurosci"},{"key":"BF1300720_CR41","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00656-1","volume":"383","author":"MS Mascia","year":"1999","unstructured":"Mascia MS, Obinu MC, Ledent C, Parmentier M, Bohme GA, Imperato A et al (1999). Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. Eur J Pharmacol 383: R1\u2013R2.","journal-title":"Eur J Pharmacol"},{"key":"BF1300720_CR42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561\u2013564.","journal-title":"Nature"},{"key":"BF1300720_CR43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/00008877-200312000-00002","volume":"14","author":"PJ McLaughlin","year":"2003","unstructured":"McLaughlin PJ, Winston K, Swezey L, Wisniecki A, Aberman J, Tardif DJ et al (2003). The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol 14: 583\u2013588.","journal-title":"Behav Pharmacol"},{"key":"BF1300720_CR44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.npp.1300380","volume":"29","author":"P Munzar","year":"2004","unstructured":"Munzar P, Tanda G, Justinova Z, Goldberg SR (2004). Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 29: 705\u2013717.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300720_CR45","unstructured":"National Research Council (2003). Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research. The National Academy Press: Washington, DC, USA."},{"key":"BF1300720_CR46","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0091-3057(90)90024-C","volume":"37","author":"P Nencini","year":"1990","unstructured":"Nencini P, Graziani M (1990). Opiatergic modulation of preparatory and consummatory components of feeding and drinking. Pharmacol Biochem Behav 37: 531\u2013537.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300720_CR47","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D (2003). The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873\u2013884.","journal-title":"Nat Rev Neurosci"},{"key":"BF1300720_CR48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1749-6632.1996.tb15121.x","volume":"780","author":"T Reisine","year":"1996","unstructured":"Reisine T, Law SF, Blake A, Tallent M (1996). Molecular mechanisms of opiate receptor coupling to G proteins and effector systems. Ann NY Acad Sci 780: 168\u2013175.","journal-title":"Ann NY Acad Sci"},{"key":"BF1300720_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF00427952","volume":"80","author":"TW Robbins","year":"1983","unstructured":"Robbins TW, Watson BA, Gaskin M, Ennis C (1983). Contrasting interactions of pipradrol, D-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement. Psychopharmacology (Berl) 80: 113\u2013119.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF02245526","volume":"111","author":"DC Roberts","year":"1993","unstructured":"Roberts DC, Bennett SA (1993). Heroin self-administration in rats under a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 111: 215\u2013218.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR51","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1523\/JNEUROSCI.21-03-00823.2001","volume":"21","author":"JJ Rodriguez","year":"2001","unstructured":"Rodriguez JJ, Mackie K, Pickel VM (2001). Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. J Neurosci 21: 823\u2013833.","journal-title":"J Neurosci"},{"key":"BF1300720_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s002130100910","volume":"159","author":"NE Rowland","year":"2001","unstructured":"Rowland NE, Mukherjee M, Robertson K (2001). Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology (Berl) 159: 111\u2013116.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.035063","volume":"305","author":"JD Salamone","year":"2003","unstructured":"Salamone JD, Correa M, Mingote S, Weber SM (2003). Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther 305: 1\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300720_CR54","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1037\/0735-7044.110.5.1049","volume":"110","author":"MC Schmelzeis","year":"1996","unstructured":"Schmelzeis MC, Mittleman G (1996). The hippocampus and reward: effects of hippocampal lesions on progressive-ratio responding. Behav Neurosci 110: 1049\u20131066.","journal-title":"Behav Neurosci"},{"key":"BF1300720_CR55","first-page":"179","volume":"9","author":"J Simiand","year":"1998","unstructured":"Simiand J, Keane M, Keane PE, Soubrie P (1998). SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9: 179\u2013181.","journal-title":"Behav Pharmacol"},{"key":"BF1300720_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1124\/jpet.102.047928","volume":"306","author":"M Solinas","year":"2003","unstructured":"Solinas M, Panlilio LV, Antoniou K, Pappas LA, Goldberg SR (2003). The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J Pharmacol Exp Ther 306: 93\u2013102.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300720_CR57","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1111\/j.0953-816X.2004.03420.x","volume":"19","author":"M Solinas","year":"2004","unstructured":"Solinas M, Zangen A, Thiriet N, Goldberg SR (2004). Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of delta-9-tetrahydrocannabinol. Eur J Neurosci 19: 3183\u20133192.","journal-title":"Eur J Neurosci"},{"key":"BF1300720_CR58","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/sj.bjp.0705932","volume":"143","author":"MS Spano","year":"2004","unstructured":"Spano MS, Fattore L, Cossu G, Deiana S, Fadda P, Fratta W (2004). CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat. Br J Pharmacol 143: 343\u2013350.","journal-title":"Br J Pharmacol"},{"key":"BF1300720_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00213-003-1485-z","volume":"169","author":"G Tanda","year":"2003","unstructured":"Tanda G, Goldberg SR (2003). Cannabinoids: reward, dependence, and underlying neurochemical mechanisms\u2014a review of recent preclinical data. Psychopharmacology (Berl) 169: 115\u2013134.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR60","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","volume":"276","author":"G Tanda","year":"1997","unstructured":"Tanda G, Pontieri FE, Di Chiara G (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276: 2048\u20132050.","journal-title":"Science"},{"key":"BF1300720_CR61","doi-asserted-by":"crossref","unstructured":"Thornton-Jones ZD, Vickers SP, Clifton PG (2004). The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food. Psychopharmacology (Berl) (online); doi: 10.1007\/s00213-004-2047-8.","DOI":"10.1007\/s00213-004-2047-8"},{"key":"BF1300720_CR62","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1046\/j.0953-816x.2001.01558.x","volume":"13","author":"O Valverde","year":"2001","unstructured":"Valverde O, Noble F, Beslot F, Dauge V, Fournie-Zaluski MC, Roques BP (2001). Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur J Neurosci 13: 1816\u20131824.","journal-title":"Eur J Neurosci"},{"key":"BF1300720_CR63","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/sj.npp.1300117","volume":"28","author":"D Vigano","year":"2003","unstructured":"Vigano D, Grazia Cascio M, Rubino T, Fezza F, Vaccani A, Di Marzo V et al (2003). Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. Neuropsychopharmacology 28: 1160\u20131167.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300720_CR64","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/j.1460-9568.2004.03645.x","volume":"20","author":"D Vigano","year":"2004","unstructured":"Vigano D, Valenti M, Cascio MG, Di Marzo V, Parolaro D (2004). Changes in endocannabinoid levels in a rat model of behavioral sensitization to morphine. Eur J Neurosci 20: 1849\u20131857.","journal-title":"Eur J Neurosci"},{"key":"BF1300720_CR65","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002130050953","volume":"143","author":"CM Williams","year":"1999","unstructured":"Williams CM, Kirkham TC (1999). Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 143: 315\u2013317.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300720_CR66","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0031-9384(02)00725-4","volume":"76","author":"CM Williams","year":"2002","unstructured":"Williams CM, Kirkham TC (2002a). Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol Behav 76: 241\u2013250.","journal-title":"Physiol Behav"},{"key":"BF1300720_CR67","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0091-3057(01)00694-3","volume":"71","author":"CM Williams","year":"2002","unstructured":"Williams CM, Kirkham TC (2002b). Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71: 333\u2013340.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300720_CR68","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0031-9384(98)00170-X","volume":"65","author":"CM Williams","year":"1998","unstructured":"Williams CM, Rogers PJ, Kirkham TC (1998). Hyperphagia in pre-fed rats following oral delta9-THC. Physiol Behav 65: 343\u2013346.","journal-title":"Physiol Behav"},{"key":"BF1300720_CR69","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0149-7634(02)00041-6","volume":"26","author":"MR Yeomans","year":"2002","unstructured":"Yeomans MR, Gray RW (2002). Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 26: 713\u2013728.","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300720","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T02:48:32Z","timestamp":1684205312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,6]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["BF1300720"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300720","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,6]]}}}